BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
August 23, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
August 22, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Joins Webull Corporate Connect
June 29, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
June 27, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
May 03, 2023 09:00 ET
|
BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Atrial Fibrillation Market Worth $20.92 Billion, Globally, by 2028 at 14.11% CAGR | The Insight Partners
April 04, 2023 09:45 ET
|
The Insight Partners
Pune, INDIA., April 04, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Treatment Type, End User,...
BioSig Announces New Advisory Board Member Edwin Wang
March 27, 2023 08:38 ET
|
BioSig Technologies, Inc.
Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...